Apimeds Pharmaceuticals Stock Forecast - Triple Exponential Smoothing

APUS Stock   1.77  0.19  9.69%   
The Triple Exponential Smoothing forecasted value of Apimeds Pharmaceuticals US, on the next trading day is expected to be 1.75 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.48. Apimeds Stock Forecast is based on your current time horizon.
Total Current Liabilities is likely to gain to about 1.1 M in 2025, whereas Total Assets are likely to drop slightly above 12.4 K in 2025.
Triple exponential smoothing for Apimeds Pharmaceuticals - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Apimeds Pharmaceuticals prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Apimeds Pharmaceuticals price movement. However, neither of these exponential smoothing models address any seasonality of Apimeds Pharmaceuticals.

Apimeds Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 19th of December

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Apimeds Pharmaceuticals US, on the next trading day is expected to be 1.75 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.06, and the sum of the absolute errors of 9.48.
Please note that although there have been many attempts to predict Apimeds Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Apimeds Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Apimeds Pharmaceuticals Stock Forecast Pattern

Backtest Apimeds PharmaceuticalsApimeds Pharmaceuticals Price PredictionBuy or Sell Advice 

Apimeds Pharmaceuticals Forecasted Value

In the context of forecasting Apimeds Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Apimeds Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 10.90, respectively. We have considered Apimeds Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.77
1.75
Expected Value
10.90
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Apimeds Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Apimeds Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0302
MADMean absolute deviation0.1607
MAPEMean absolute percentage error0.0675
SAESum of the absolute errors9.4792
As with simple exponential smoothing, in triple exponential smoothing models past Apimeds Pharmaceuticals observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Apimeds Pharmaceuticals US, observations.

Predictive Modules for Apimeds Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apimeds Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Apimeds Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.101.9611.09
Details
Intrinsic
Valuation
LowRealHigh
0.091.8811.01
Details

Other Forecasting Options for Apimeds Pharmaceuticals

For every potential investor in Apimeds, whether a beginner or expert, Apimeds Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Apimeds Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Apimeds. Basic forecasting techniques help filter out the noise by identifying Apimeds Pharmaceuticals' price trends.

Apimeds Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apimeds Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Apimeds Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Apimeds Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Apimeds Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Apimeds Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Apimeds Pharmaceuticals' current price.

Apimeds Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Apimeds Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apimeds Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Apimeds Pharmaceuticals stock market strength indicators, traders can identify Apimeds Pharmaceuticals US, entry and exit signals to maximize returns.

Apimeds Pharmaceuticals Risk Indicators

The analysis of Apimeds Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Apimeds Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting apimeds stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Apimeds Stock Analysis

When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.